Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARIX.L Share News (ARIX)

  • There is currently no data for ARIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Arix's VelosBio Pockets USD137 Million In Fundraise

Wed, 08th Jul 2020 15:52

Arix Bioscience PLC - healthcare investor - Portfolio company VelosBio Inc completes USD137 million series B financing, amid "strong interest from leading global healthcare investors".

Current stock price: 85.66 pence

Year-to-date change: down 20%

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
10 Aug 2020 13:15

IN BRIEF: Arix Bioscience Investee Plans LB-001 Trial After US FDA Ok

IN BRIEF: Arix Bioscience Investee Plans LB-001 Trial After US FDA Ok

Read more
20 Jul 2020 20:02

IN BRIEF: Arix Bioscience Notes Positive Data From Amplyx's Study

IN BRIEF: Arix Bioscience Notes Positive Data From Amplyx's Study

Read more
10 Jul 2020 14:21

IN BRIEF: Arix's Atox To Submit Reltecimod Drug Application To US FDA

IN BRIEF: Arix's Atox To Submit Reltecimod Drug Application To US FDA

Read more
1 Jun 2020 15:54

UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks

UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks

Read more
28 May 2020 16:15

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
20 May 2020 10:24

Arix portfolio firm Amplyx extends its series C funding

(Sharecast News) - Venture capital company Arix Bioscience noted on Wednesday that its portfolio company, Amplyx Pharmaceuticals, has closed a $53m (£43.22m) series C extension.

Read more
27 Apr 2020 16:59

Arix Bioscience Notes First Patient Dosed In Harpoon's HPN217 Trial

Arix Bioscience Notes First Patient Dosed In Harpoon's HPN217 Trial

Read more
17 Apr 2020 06:08

Syncona, Arix Note US FDA Acceptance Of Autolus Drug Application

Syncona, Arix Note US FDA Acceptance Of Autolus Drug Application

Read more
6 Apr 2020 15:47

UK EXECUTIVE CHANGE SUMMARY: Two Co-Founders Leave Arix Bioscience

UK EXECUTIVE CHANGE SUMMARY: Two Co-Founders Leave Arix Bioscience

Read more
12 Mar 2020 14:17

Arix Biosciences Invests Further Into Imara Following US IPO Pricing

Arix Biosciences Invests Further Into Imara Following US IPO Pricing

Read more
10 Mar 2020 11:49

Arix Bioscience net asset value slides amid 'volatility' in holdings

(Sharecast News) - Biotechnology venture capital company Arix Bioscience reported a year-end net asset value of ?202m in its annual results on Tuesday, or 149p per share, equating to a 25% decline in net asset value per share for the year, compared to a 32% increase in 2018.

Read more
10 Mar 2020 11:06

Arix Bioscience Net Asset Value Declines In 2019 Amid Challenges

Arix Bioscience Net Asset Value Declines In 2019 Amid Challenges

Read more
3 Mar 2020 19:02

Arix Bioscience Investee US IPO Price Set At USD16 To USD18 Per Share

Arix Bioscience Investee US IPO Price Set At USD16 To USD18 Per Share

Read more
3 Mar 2020 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.